9 Tips to Serialization Readiness

 Excellis Health Solutions and 3C Excellis Europe have been busy recently speaking at various events and conferences include The TrackTS andFlyPharma conferences. 3C Excellis Europe spoke and attended both of these events. During his time at both events, he delivered expert serialization advice and uncovered the current state of serialization readiness in the pharma sector. We’ve put together a short series of blog posts on our experience at the events.

(more…)

The EU-FMD clock is ticking!

This article examines key requirements of the “Safety Features” Delegated Regulation and discusses the implications for pharmaceutical manufacturers and other participants in the European pharmaceutical supply chain.

Issue 28- March 2016
Industry Pharmacy

Read Now

 

Pharmaceutical Commerce Magazine invites you to view this free webinar: Serialization Lessons from the Front Lines of Distribution

Join subject matter experts from AmerisourceBergen, Excellis Health Solutions and Acsis as we discuss the next phase of the DSCSA requirements, with a focus on warehousing and distribution. In this webinar, moderated by Pharmaceutical Commerce, we will review where our industry is today on the journey toward full DSCSA compliance and how companies can benefit from going beyond compliance.

(more…)

EHS/PDA Webinar: Managing Global Serialization Program Rollouts

Learn about DSCSA and other global regulatory requirements impacting the industry and specifically, your company from 2015-2023. Find out how these regulations can help transform business processes across your enterprise. CEO of Excellis Health Solutions, Greg Cathcart, will be leading a discussion on gaining a perspective on the latest global regulations and planning and implementing your Global Serialization Initiative. The interactive presentation will offer best practices and strategies for updated serialization programs.

When: December 15, 2015
Time: 1:00 pm
Who: Greg Cathcart, Excellis Health Solutions CEO
Where: Webex


For more details, click here.